Assembly Biosciences, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Assembly Biosciences, Inc. (ASMB) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 2.30% for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2014-08-14
- Assembly Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 2.30%, a 75.57% increase year-over-year.
- Assembly Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 1.31%.
- Assembly Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 3.89%, a 92.57% increase from fiscal 2012.
- Assembly Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 2.02%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2014-06-30 | 2.30% 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | 2.30% 10-Q · filed 2014-05-14 | ||
| 2013-12-31 | 3.89% 10-K · filed 2014-03-31 | ||
| 2013-03-31 | 1.31% 10-Q · filed 2013-05-10 | ||
| 2012-12-31 | 2.02% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |